Mini-Symposium - Challenges in bioequivalence for inhaled products

Monday 14th of April 2014
SY04, 1 hours

Chair: Vinod Shah (USA)

Room:  Meeting room 210

09.00 – 09.30    IVIVCs and the potential impact of variability in regional airway deposition patterns on the bioequivalence of pulmonary products
(MO-05-01) Andy Clark, Novartis, California, USA

09.30 – 10.00     The role of pharmacokinetics in bioequivalence ofstudies of inhalation drugs
(MO-05-02) Guenther Hochhaus, University of Florida, USA